Revium Rx. (RVRC)
OTCMKTS
· Delayed Price · Currency is USD
1.670
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EST
Revium Rx. Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2009 | 2008 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '09 Dec 31, 2009 | 2008 |
| Revenue | - | - | - | - | 0.66 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | -77.96% | Upgrade
|
| Cost of Revenue | - | - | - | - | 0.55 | Upgrade
|
| Gross Profit | - | - | - | - | 0.1 | Upgrade
|
| Selling, General & Admin | 1.82 | 1.41 | 0.16 | 1.12 | 0.21 | Upgrade
|
| Research & Development | 1.64 | 2.16 | 0.85 | 0.07 | - | Upgrade
|
| Operating Expenses | 3.46 | 3.57 | 1 | 1.19 | 0.21 | Upgrade
|
| Operating Income | -3.46 | -3.57 | -1 | -1.19 | -0.1 | Upgrade
|
| Interest Expense | - | -0 | - | -0.02 | - | Upgrade
|
| Interest & Investment Income | 0.06 | 0.07 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | 0.02 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -3.41 | -3.51 | -0.99 | -1.21 | -0.1 | Upgrade
|
| Impairment of Goodwill | -8.65 | - | - | - | - | Upgrade
|
| Asset Writedown | -1.04 | - | - | - | - | Upgrade
|
| Pretax Income | -13.09 | -3.51 | -0.99 | -1.21 | -0.1 | Upgrade
|
| Income Tax Expense | 0.36 | - | - | - | - | Upgrade
|
| Net Income | -13.45 | -3.51 | -0.99 | -1.21 | -0.1 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | -0.99 | - | - | Upgrade
|
| Net Income to Common | -13.45 | -3.51 | - | -1.21 | -0.1 | Upgrade
|
| Shares Outstanding (Basic) | 61 | 26 | 29 | 28 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 61 | 26 | 29 | 28 | 0 | Upgrade
|
| Shares Change (YoY) | 136.92% | -12.69% | 4.44% | 48170.60% | -15.69% | Upgrade
|
| EPS (Basic) | -0.22 | -0.14 | - | -0.04 | -1.78 | Upgrade
|
| EPS (Diluted) | -0.22 | -0.14 | - | -0.04 | -1.78 | Upgrade
|
| Free Cash Flow | -2.54 | -1.21 | -1.02 | -0.82 | 3.23 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.05 | -0.04 | -0.03 | 55.51 | Upgrade
|
| Gross Margin | - | - | - | - | 15.59% | Upgrade
|
| Operating Margin | - | - | - | - | -15.79% | Upgrade
|
| Profit Margin | - | - | - | - | -15.79% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | 491.85% | Upgrade
|
| EBITDA | -3.46 | -3.56 | -1 | -1.19 | - | Upgrade
|
| D&A For EBITDA | 0.01 | 0 | 0 | 0 | - | Upgrade
|
| EBIT | -3.46 | -3.57 | -1 | -1.19 | -0.1 | Upgrade
|
| EBIT Margin | - | - | - | - | -15.79% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.